Table 5.

CTLA-4 and IL-6 co-existing genotypes, along with their relative risk, odds ratio and p-value in HCV-induced HCC patients

Genotype (CTLA4 + IL6)	Number		Relative Risk (95% CI)	Odds Ratio (95% CI)	P-value
	Patients (%)	Control (%)
GG + TT	11 (5.16%)	14 (6.48%)	0.88 (0.52—1.28)	0.78 (0.35—1.71)	0.68
GG + TC	25 (11.74%)	107 (48.61%)	0.31 (0.21—0.43)	0.140 (0.085—0.23)	< 0.0001
GG + CC	43 (20.19%)	40 (18.52%)	1.05 (0.82—1.31)	1.113 (0.68—1.81)	0.71
GA + TT	18 (8.45%)	6 (2.91%)	1.51 (1.10—1.85)	3.077 (1.26—7.56)	0.01
GA + TC	21 (9.86%)	29 (13.43%)	0.82 (0.57—1.12)	0.7053 (0.39—1.27)	0.29
GA + CC	95 (44.60%)	20 (9.26%)	2.19 (1.86—2.59)	7.890 (4.63—13.72)	< 0.0001